Revolution Medicines, Inc. (RVMD) operating KPIs

RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 3/30

$191.31+1.04 (+0.55%)

Close on Oct 30, 2026Market cap $41.00BP/E –Yield –

KPIs

Operating metrics that drive Revolution Medicines's business

Coming soon

This tab will track the numbers specific to Revolution Medicines's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.